Enlivex Ltd. (ENLV)
2.54
-0.07
(-2.68%)
USD |
NASDAQ |
Oct 29, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Enlivex Enterprise Value : 54.67M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 54.67M |
| October 28, 2026 | 55.84M |
| October 27, 2026 | 57.36M |
| October 26, 2026 | 55.73M |
| October 23, 2026 | 58.61M |
| October 22, 2026 | 65.56M |
| October 21, 2026 | 66.37M |
| October 20, 2026 | 72.16M |
| October 19, 2026 | 67.77M |
| October 16, 2026 | 67.12M |
| October 15, 2026 | 72.29M |
| October 14, 2026 | 69.98M |
| October 13, 2026 | 71.81M |
| October 12, 2026 | 80.05M |
| October 09, 2026 | 80.32M |
| October 08, 2026 | 86.51M |
| October 07, 2026 | 94.43M |
| October 06, 2026 | 103.53M |
| October 05, 2026 | 109.40M |
| October 02, 2026 | 116.22M |
| October 01, 2026 | 125.75M |
| September 30, 2026 | 147.32M |
| September 29, 2026 | 141.21M |
| September 28, 2026 | 150.34M |
| September 25, 2026 | 172.83M |
| Date | Value |
|---|---|
| September 24, 2026 | 175.03M |
| September 23, 2026 | 184.27M |
| September 22, 2026 | 186.00M |
| September 21, 2026 | 198.49M |
| September 18, 2026 | 229.14M |
| September 17, 2026 | 207.76M |
| September 16, 2026 | 230.35M |
| September 15, 2026 | 249.63M |
| September 14, 2026 | 244.73M |
| September 11, 2026 | 270.32M |
| September 10, 2026 | 276.03M |
| September 09, 2026 | 292.00M |
| September 08, 2026 | 310.85M |
| September 04, 2026 | 308.15M |
| September 03, 2026 | 324.31M |
| September 02, 2026 | 348.55M |
| September 01, 2026 | 356.63M |
| August 31, 2026 | 356.63M |
| August 28, 2026 | 375.48M |
| August 27, 2026 | 409.15M |
| August 26, 2026 | 419.92M |
| August 25, 2026 | 421.26M |
| August 24, 2026 | 418.57M |
| August 21, 2026 | 407.80M |
| August 20, 2026 | 415.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Polyrizon Ltd. | -- |
| NovelStem International Corp. | 2.047M |
| Brainstorm Cell Therapeutics, Inc. | 11.38M |
| Summit Therapeutics, Inc. | 12.18B |
| PeptiDream Inc. | 825.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.892B |
| Total Expenses (Quarterly) | -1.892B |
| EPS Diluted (Quarterly) | 97.84 |
| Earnings Yield | 19.03K% |